Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction
- 1 March 2005
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 95 (5) , 553-557
- https://doi.org/10.1016/j.amjcard.2004.10.034
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJournal of the American College of Cardiology, 2001
- Gene Expression of Brain Natriuretic Peptide in Isolated Atrial and Ventricular Human MyocardiumCirculation, 2000
- Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable anginaHeart, 2000
- Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Heart, 1996
- Increased plasma levels of B-type natriuretic peptide in patients with unstable anginaAmerican Heart Journal, 1996
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Relationship between Plasma Level of Brain Natriuretic Peptide and Myocardial Infarct SizeCardiology, 1994
- Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993
- Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation, 1993